The longer your telomeres, the larger your nevus?

American Journal of Dermatopathology

Volumn 25, Issue 1, 2003, Pages 83-84

  Bastian, Boris C ^a,b  

^a Department of Dermatology ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SCATTER FACTOR;

CELL DIVISION; CELL PROLIFERATION; CLINICAL FEATURE; DNA SEQUENCE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC RISK; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MELANOCYTIC NEVUS; MELANOMA; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN BINDING; RISK ASSESSMENT; SHORT SURVEY; SIGNAL TRANSDUCTION; TELOMERE;

EID: 0037304616     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200302000-00019     Document Type: Short Survey

References (14)

1. Clemmensen OJ, Kroon S. The histology of 'congenital features' in early acquired melanocytic nevi. J Am Acad Dermatol 1988;19:742-6.
2. Everett MA. Histopathology of congenital pigmented nevi. Am J Dermatopathol 1989;11:11-2.
3. Marghoob AA, Schoenbach SP, Kopf AW, et al. Large congenital melanocytic nevi and the risk for the development of malignant melanoma: a prospective study. Arch Dermatol 1996;132:170-5.
4. Carr J, Mackie RM. Point mutations in the N-ras oncogene in malignant melanoma and congenital nevi. Br J Dermatol 1994;131:72-7.
5. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increases of HRAS in Spitz nevi with distinctive histopathologic features. Am J Pathol 2000;157:967-72.
6. Takayama H, LaRochelle WJ, Anver M, et al. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. PNAS 1996;93:5866-71.
7. Takayama H, Nagashima Y, Hara M, et al. Immunohistochemical detection of the c-met proto-oncogene product in the congenital melanocytic nevus of an infant with neurocutaneous melanosis. J Am Acad Dermatol 2001;44:538-40.
8. Herlyn M, Satyamoorthy K. Activated ras: yet another player in melanoma? Am J Pathol 1996;149:739-44.
9. Mathon NF, Lloyd AC. Cell senescence and cancer. Nat Rev Cancer 2001;1:203-13.
10. Abdel-Malek ZA, Swope VB, Nordlund JJ, et al. Proliferation and propagation of human melanocytes in vitro are affected by donor age and anatomical site. Pigment Cell Res 1994;7:116-22.
11. Bastian BC, LeBoit PE, Hamm H, et al. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 1998;58:2170-5.
12. Bastian BC, Kashani-Sabet M, Hamm H, et al. Gene amplifications characterize acral melanoma and permit the detection of occult cells in the surrounding skin. Cancer Res 2000;60:1968-73.
13. Bastian BC, Wesselmann U, Pinkel D, et al. Molecular cytogenetic analysis of Spitz nevi show clear differences to melanoma. J Invest Dermatol 1999;113:1065-9.
14. Bastian BC, Xiong J, Frieden IJ, et al. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. Am J Pathol 2002;161:163-9.